Skip to content

Efficacy and Safety of Cyclopofol During Total Intravenous Anesthesia in Elderly Patients: A randomized controlled non-inferiority study

Efficacy and Safety of Cyclopofol During Total Intravenous Anesthesia in Elderly Patients: A randomized controlled non-inferiority study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060688
Enrollment
Unknown
Registered
2022-06-08
Start date
2022-05-25
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia for the elderly

Interventions

ciprofol :Ciprofol: induction 0.3mg/kg + maintenance 0.8mg/kg/h
medium/long-chain propofol:Medium/long chain propofol: induction 2mg/kg + maintenance 4mg/kg/h

Sponsors

The First Hospital, LanZhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Elective surgery at the age of 65-85; 2) Body mass index (BMI) 18-30kg/m2; 3) ASA classification I-II or ASA III is well controlled; 4) The estimated intra-operative blood loss is less than 1000ml; 5) The duration of general anesthesia is more than 30 minutes and anesthesia machine is required to control ventilation; 6) No serious liver and kidney dysfunction;

Exclusion criteria

Exclusion criteria: 1) Suffering from serious cardiovascular and respiratory diseases; 2) Patients undergoing cardiovascular, respiratory, liver surgery, and brain surgery; 3) Allergic to the test drug or ingredient; 4) There are contraindications to the test drug; 5) Malignant hyperthermia family history; 6) Patients with known difficult airways; 7) Patients who cannot perform MMSE cognitive function assessment; 8) Joined other drug studies within 3 months before surgery;

Design outcomes

Primary

MeasureTime frame
rate of Induction success;length of induction;drug consumption;hypotension;bradycardia;Injection pain;

Secondary

MeasureTime frame
AI value;

Countries

China

Contacts

Public ContactLv Xinghua,Wang Hao

The First Hospital, LanZhou University

13309449637@163.com+86 13919266686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026